# Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)

Source: https://onco.cc/trials/nct00626444/  
OnCo record `nct00626444` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of High-dose intravenous vitamin C in Non-Hodgkin lymphoma, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, recorded as terminated on the registry.

## Summary

Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) is a phase 2 interventional study registered as NCT00626444 by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, with 2 participants recorded, started 2008-02 and due to reach its primary completion in 2011-12. Interventions recorded: Intravenous vitamin C. Conditions recorded: Non-Hodgkin Lymphoma.

Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Non-Hodgkin lymphoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00626444
- Phase: 2
- Setting: Phase II Trial of High Dose Intravenous Vitamin C in Patients With Refractory Non-Hodgkin Lymphoma
- Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Enrolled: 2

## Sources

- ClinicalTrials.gov NCT00626444: https://clinicaltrials.gov/study/NCT00626444

## Connected records

- cancers: [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)
- technologies: [High-dose intravenous vitamin C](https://onco.cc/technologies/high-dose-vitamin-c/)

---
JSON: https://onco.cc/api/v1/entities/nct00626444.json